Howe Jolanda — SEC Form 4 filings
SEC reporting owner CIK 1974200. 23 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2024-01-09 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 20 filings — 133,197 shares, $9,137,095 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 40,000 shares @ $100.00 ($4,000,000) in Mirum Pharmaceuticals, Inc., filed 2026-08-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | SVP, GLOBAL CONTROLLER | 23 | — | 24 legs · 133,197 sh · $9,137,095 | 42 |
Form 4 filings — Howe Jolanda
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 658 @ $100 | EDGAR |
| 2026-08-19 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 40,000 @ $6.27 · Sale (S): 40,000 @ $100 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 1,840 @ $105.29 | EDGAR |
| 2026-07-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 2,721 @ $120 | EDGAR |
| 2026-06-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 2,594 @ $101.95 | EDGAR |
| 2026-03-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,658 · Option exercise (M): 6,000 · Sale (S): 4,732 @ $91.98 · Option exercise (M): 2,658 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,771 · Sale (S): 968 @ $103.30 · Option exercise (M): 1,771 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 7,680 (derivative) @ $0 · Grant/award (A): 4,970 (derivative) @ $0 · Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,500 · Sale (S): 842 @ $96.19 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,542 · Sale (S): 926 @ $93.33 · Option exercise (M): 1,542 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 10,000 @ $6.27 · Sale (S): 10,000 @ $58 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,041 · Sale (S): 564 @ $48.25 · Sale (S): 477 @ $49.08 · Option exercise (M): 1,041 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 2,415 @ $44.45 | EDGAR |
| 2025-03-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,315 · Sale (S): 2,900 @ $44.21 · Option exercise (M): 52,900 @ $2.94 · Sale (S): 50,111 @ $44.33 · Sale (S): 2,789 @ $44.75 · Sale (S): 1,806 @ $44.36 · +2 more | EDGAR |
| 2025-02-04 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,772 · Sale (S): 1,064 @ $48.22 · Option exercise (M): 1,772 (derivative) @ $0 | EDGAR |
| 2025-01-27 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,500 · Sale (S): 902 @ $47.92 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 18,500 (derivative) @ $0 · Grant/award (A): 4,625 (derivative) @ $0 · Grant/award (A): 7,973 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,250 · Sale (S): 750 @ $42.82 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,500 @ $2.94 · Sale (S): 2,500 @ $47.10 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,042 · Sale (S): 375 @ $34 · Option exercise (M): 1,042 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,772 · Sale (S): 735 @ $26.19 · Option exercise (M): 1,772 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 18,000 (derivative) @ $0 · Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 1,250 · Sale (S): 528 @ $28.04 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1974200 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →